UBS Group’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,095
| Closed | -$69K | – | 11803 |
|
|
2022
Q2 | $69K | Sell |
2,095
-11,229
| -84% | -$355K | ﹤0.01% | 5695 |
|
|
2022
Q1 | $351K | Sell |
13,324
-26,202
| -66% | -$640K | ﹤0.01% | 4950 |
|
|
2021
Q4 | $938K | Sell |
39,526
-20,737
| -34% | -$512K | ﹤0.01% | 4447 |
|
|
2021
Q3 | $1.51M | Buy |
60,263
+23,005
| +62% | +$586K | ﹤0.01% | 3826 |
|
|
2021
Q2 | $968K | Sell |
37,258
-13,335
| -26% | -$363K | ﹤0.01% | 4203 |
|
|
2021
Q1 | $1.3M | Sell |
50,593
-27,668
| -35% | -$709K | ﹤0.01% | 3995 |
|
|
2020
Q4 | $1.57M | Sell |
78,261
-13,853
| -15% | -$271K | ﹤0.01% | 3627 |
|
|
2020
Q3 | $1.58M | Sell |
92,114
-12,346
| -12% | -$233K | ﹤0.01% | 3280 |
|
|
2020
Q2 | $2.28M | Buy |
104,460
+71,554
| +217% | +$1.64M | ﹤0.01% | 2743 |
|
|
2020
Q1 | $761K | Sell |
32,906
-42,325
| -56% | -$1.23M | ﹤0.01% | 3586 |
|
|
2019
Q4 | $2.48M | Buy |
75,231
+28,126
| +60% | +$901K | ﹤0.01% | 3334 |
|
|
2019
Q3 | $1.5M | Buy |
47,105
+34,609
| +277% | +$1.01M | ﹤0.01% | 3593 |
|
|
2019
Q2 | $321K | Buy |
12,496
+8,155
| +188% | +$208K | ﹤0.01% | 4610 |
|
|
2019
Q1 | $110K | Sell |
4,341
-692
| -14% | -$20.6K | ﹤0.01% | 5003 |
|
|
2018
Q4 | $171K | Sell |
5,033
-129
| -2% | -$4.19K | ﹤0.01% | 5088 |
|
|
2018
Q3 | $184K | Buy |
5,162
+1,452
| +39% | +$51.3K | ﹤0.01% | 5134 |
|
|
2018
Q2 | $128K | Sell |
3,710
-2,108
| -36% | -$73.9K | ﹤0.01% | 5268 |
|
|
2018
Q1 | $196K | Sell |
5,818
-232,735
| -98% | -$7.37M | ﹤0.01% | 4796 |
|
|
2017
Q4 | $9.11M | Buy |
238,553
+47,883
| +25% | +$1.91M | ﹤0.01% | 1803 |
|
|
2017
Q3 | $7.15M | Buy |
190,670
+28,308
| +17% | +$999K | ﹤0.01% | 1877 |
|
|
2017
Q2 | $6.06M | Buy |
162,362
+87,454
| +117% | +$3.16M | ﹤0.01% | 1969 |
|
|
2017
Q1 | $2.94M | Buy |
74,908
+34,753
| +87% | +$1.3M | ﹤0.01% | 2571 |
|
|
2016
Q4 | $1.4M | Buy |
40,155
+35,844
| +831% | +$1.41M | ﹤0.01% | 3250 |
|
|
2016
Q3 | $169K | Sell |
4,311
-1,277
| -23% | -$50.9K | ﹤0.01% | 4661 |
|
|
2016
Q2 | $211K | Buy |
5,588
+101
| +2% | +$3.38K | ﹤0.01% | 4509 |
|
|
2016
Q1 | $211K | Sell |
5,487
-23,889
| -81% | -$890K | ﹤0.01% | 4454 |
|
|
2015
Q4 | $1.41M | Buy |
29,376
+21,558
| +276% | +$998K | ﹤0.01% | 3130 |
|
|
2015
Q3 | $309K | Sell |
7,818
-457
| -6% | -$19.4K | ﹤0.01% | 4283 |
|
|
2015
Q2 | $352K | Sell |
8,275
-1,132
| -12% | -$45.1K | ﹤0.01% | 4397 |
|
|
2015
Q1 | $372K | Sell |
9,407
-26,126
| -74% | -$963K | ﹤0.01% | 4383 |
|
|
2014
Q4 | $1.28M | Buy |
+35,533
| New | +$1.19M | ﹤0.01% | 3371 |
|
Other funds holding NTUS
UBS Group's NTUS Position: Q3 2022 in Review
UBS Group sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 2,095 shares — an estimated $69K sold.
UBS Group first reported a position in NTUS in Q4 2014 and held it in 31 quarters. The position peaked at $9.11M in Q4 2017. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- UBS Group reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- UBS Group sold 2,095 Natus Medical Inc shares in Q3 2022, an estimated $69K.
- UBS Group first reported a position in Natus Medical Inc in Q4 2014 and held it in 31 quarters.
- UBS Group's Natus Medical Inc position peaked at $9.11M in Q4 2017.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.